Contributor:

Daniel Kiernan MD, Seenu Hariprasad MD

25-g Vitreous Removal Using Triesence Visualization

Daniel Kiernan MD, Seenu Hariprasad MD

A Treatment Paradigm for Wet AMD

Daniel F. Kiernan, MD, FACS; Prethy Rao, MD, MPH, FACS; Andrew M. Schimel, MD

Phase 2/3 Clinical Trial Data for EYLEA HD® (aflibercept) Injection 8 mg for the Treatment of DME

Daniel F. Kiernan, MD, FACS; Prethy Rao, MD, MPH, FACS; Andrew M. Schimel, MD

Phase 3 Clinical Trial Data for EYLEA HD® (aflibercept) Injection 8 mg for the Treatment of Wet AMD

Daniel F. Kiernan, MD, FACS; Prethy Rao, MD, MPH, FACS; Andrew M. Schimel, MD

Chronic Postoperative Inflammation: Initial Encounters

John Kitchens, MD; Lisa Faia, MD; and Daniel Kiernan, MD